Cargando…

Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap

PURPOSE: Hyposmia is a common feature of COVID-19 and Parkinson’s disease (PD). As parkinsonism has been reported after COVID-19, a link has been hypothesized between SARS-CoV2 infection and PD. We aimed to evaluate brain metabolic correlates of isolated persistent hyposmia after mild-to-moderate CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Morbelli, Silvia, Chiola, Silvia, Donegani, Maria Isabella, Arnaldi, Dario, Pardini, Matteo, Mancini, Raffaele, Lanfranchi, Francesco, D’amico, Francesca, Bauckneht, Matteo, Miceli, Alberto, Biassoni, Erica, Orso, Beatrice, Barisione, Emanuela, Benedetti, Luana, Gianmario, Sambuceti, Nobili, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727173/
https://www.ncbi.nlm.nih.gov/pubmed/34984501
http://dx.doi.org/10.1007/s00259-021-05666-9
_version_ 1784626460414181376
author Morbelli, Silvia
Chiola, Silvia
Donegani, Maria Isabella
Arnaldi, Dario
Pardini, Matteo
Mancini, Raffaele
Lanfranchi, Francesco
D’amico, Francesca
Bauckneht, Matteo
Miceli, Alberto
Biassoni, Erica
Orso, Beatrice
Barisione, Emanuela
Benedetti, Luana
Gianmario, Sambuceti
Nobili, Flavio
author_facet Morbelli, Silvia
Chiola, Silvia
Donegani, Maria Isabella
Arnaldi, Dario
Pardini, Matteo
Mancini, Raffaele
Lanfranchi, Francesco
D’amico, Francesca
Bauckneht, Matteo
Miceli, Alberto
Biassoni, Erica
Orso, Beatrice
Barisione, Emanuela
Benedetti, Luana
Gianmario, Sambuceti
Nobili, Flavio
author_sort Morbelli, Silvia
collection PubMed
description PURPOSE: Hyposmia is a common feature of COVID-19 and Parkinson’s disease (PD). As parkinsonism has been reported after COVID-19, a link has been hypothesized between SARS-CoV2 infection and PD. We aimed to evaluate brain metabolic correlates of isolated persistent hyposmia after mild-to-moderate COVID-19 and to compare them with metabolic signature of hyposmia in drug-naïve PD patients. METHODS: Forty-four patients who experienced hyposmia after SARS-COV2 infection underwent brain [(18)F]-FDG PET in the first 6 months after recovery. Olfaction was assessed by means of the 16-item “Sniffin’ Sticks” test and patients were classified as with or without persistent hyposmia (COVID-hyposmia and COVID-no-hyposmia respectively). Brain [(18)F]-FDG PET of post-COVID subgroups were compared in SPM12. COVID-hyposmia patients were also compared with eighty-two drug-naïve PD patients with hyposmia. Multiple regression analysis was used to identify correlations between olfactory test scores and brain metabolism in patients’ subgroups. RESULTS: COVID-hyposmia patients (n = 21) exhibited significant hypometabolism in the bilateral gyrus rectus and orbitofrontal cortex with respect to COVID-non-hyposmia (n = 23) (p < 0.002) and in middle and superior temporal gyri, medial/middle frontal gyri, and right insula with respect to PD-hyposmia (p < 0.012). With respect to COVID-hyposmia, PD-hyposmia patients showed hypometabolism in inferior/middle occipital gyri and cuneus bilaterally. Olfactory test scores were directly correlated with metabolism in bilateral rectus and medial frontal gyri and in the right middle temporal and anterior cingulate gyri in COVID-hyposmia patients (p < 0.006) and with bilateral cuneus/precuneus and left lateral occipital cortex in PD-hyposmia patients (p < 0.004). CONCLUSION: Metabolic signature of persistent hyposmia after COVID-19 encompasses cortical regions involved in olfactory perception and does not overlap metabolic correlates of hyposmia in PD.
format Online
Article
Text
id pubmed-8727173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87271732022-01-05 Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap Morbelli, Silvia Chiola, Silvia Donegani, Maria Isabella Arnaldi, Dario Pardini, Matteo Mancini, Raffaele Lanfranchi, Francesco D’amico, Francesca Bauckneht, Matteo Miceli, Alberto Biassoni, Erica Orso, Beatrice Barisione, Emanuela Benedetti, Luana Gianmario, Sambuceti Nobili, Flavio Eur J Nucl Med Mol Imaging Original Article PURPOSE: Hyposmia is a common feature of COVID-19 and Parkinson’s disease (PD). As parkinsonism has been reported after COVID-19, a link has been hypothesized between SARS-CoV2 infection and PD. We aimed to evaluate brain metabolic correlates of isolated persistent hyposmia after mild-to-moderate COVID-19 and to compare them with metabolic signature of hyposmia in drug-naïve PD patients. METHODS: Forty-four patients who experienced hyposmia after SARS-COV2 infection underwent brain [(18)F]-FDG PET in the first 6 months after recovery. Olfaction was assessed by means of the 16-item “Sniffin’ Sticks” test and patients were classified as with or without persistent hyposmia (COVID-hyposmia and COVID-no-hyposmia respectively). Brain [(18)F]-FDG PET of post-COVID subgroups were compared in SPM12. COVID-hyposmia patients were also compared with eighty-two drug-naïve PD patients with hyposmia. Multiple regression analysis was used to identify correlations between olfactory test scores and brain metabolism in patients’ subgroups. RESULTS: COVID-hyposmia patients (n = 21) exhibited significant hypometabolism in the bilateral gyrus rectus and orbitofrontal cortex with respect to COVID-non-hyposmia (n = 23) (p < 0.002) and in middle and superior temporal gyri, medial/middle frontal gyri, and right insula with respect to PD-hyposmia (p < 0.012). With respect to COVID-hyposmia, PD-hyposmia patients showed hypometabolism in inferior/middle occipital gyri and cuneus bilaterally. Olfactory test scores were directly correlated with metabolism in bilateral rectus and medial frontal gyri and in the right middle temporal and anterior cingulate gyri in COVID-hyposmia patients (p < 0.006) and with bilateral cuneus/precuneus and left lateral occipital cortex in PD-hyposmia patients (p < 0.004). CONCLUSION: Metabolic signature of persistent hyposmia after COVID-19 encompasses cortical regions involved in olfactory perception and does not overlap metabolic correlates of hyposmia in PD. Springer Berlin Heidelberg 2022-01-05 2022 /pmc/articles/PMC8727173/ /pubmed/34984501 http://dx.doi.org/10.1007/s00259-021-05666-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Morbelli, Silvia
Chiola, Silvia
Donegani, Maria Isabella
Arnaldi, Dario
Pardini, Matteo
Mancini, Raffaele
Lanfranchi, Francesco
D’amico, Francesca
Bauckneht, Matteo
Miceli, Alberto
Biassoni, Erica
Orso, Beatrice
Barisione, Emanuela
Benedetti, Luana
Gianmario, Sambuceti
Nobili, Flavio
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
title Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
title_full Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
title_fullStr Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
title_full_unstemmed Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
title_short Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
title_sort metabolic correlates of olfactory dysfunction in covid-19 and parkinson’s disease (pd) do not overlap
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727173/
https://www.ncbi.nlm.nih.gov/pubmed/34984501
http://dx.doi.org/10.1007/s00259-021-05666-9
work_keys_str_mv AT morbellisilvia metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT chiolasilvia metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT doneganimariaisabella metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT arnaldidario metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT pardinimatteo metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT manciniraffaele metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT lanfranchifrancesco metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT damicofrancesca metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT baucknehtmatteo metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT micelialberto metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT biassonierica metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT orsobeatrice metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT barisioneemanuela metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT benedettiluana metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT gianmariosambuceti metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap
AT nobiliflavio metaboliccorrelatesofolfactorydysfunctionincovid19andparkinsonsdiseasepddonotoverlap